Andere Sprachen Ovoca Bio plc

Aktien

Markt geschlossen - Irish S.E. Andere Börsenplätze 17:55:00 05.07.2024			% 5 Tage	% 1. Jan.
0,01 ^EUR	0,00 %		0,00 %	0,00 %

03.07.	ERGEBNISSE: AssetCo schlägt Namensänderung vor; i(x) Net Zero will AIM verlassen	AN
28.06.	Ovoca Bio plc berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr	CI

EARNINGS: AssetCo proposes name change; i(x) Net Zero eyes AIM exit	03.07.
Ovoca Bio plc Reports Earnings Results for the Full Year Ended December 31, 2023	28.06.
Ovoca Bio : Result of Extraordinary General Meeting	17.02.21
Ovoca Bio : Ovoca Bio Announces First Patient Enrolled in Phase II Dose Ranging Study Assessing BP-101 for HSDD	01.02.21
Ovoca Bio : Enrolls First Patient in Phase 2 Trial for Hypoactive Sexual Desire Disorder Treatment	29.01.21
Ovoca Bio : Notice of Extraordinary General Meeting	26.01.21
Ovoca Bio : Interim results for the six months ended 30 June 2020	21.09.20
Ovoca Bio : Acquisition of Remaining Minority Shareholding in IVIX LLC	25.03.20
Ovoca Bio : Form of Proxy AGM	28.06.19
Ovoca Bio : Patent news - Israel	07.05.19
Ovoca Bio : US AND EU CLINICAL DEVELOPMENT PLANS	23.04.19
Ovoca Bio : Presents at BIO-Europe Spring® 2019, Vienna	15.04.19
Ovoca Bio : Operational Update and Acquisition of Additional Interest in IVIX	27.03.19
Ovoca Bio : Primary Endpoints Met in Libicore Phase III Study	25.03.19
Ovoca Bio : is pleased to announce that IVIX has signed an agreement with Biopharma Excellence GmbH (Germany)	10.10.18
Ovoca Bio : Interim Results September 28, 2018	28.09.18
Ovoca Bio : Completion of the Acquisition of IVIX	26.09.18
Ovoca Gold : Form of Proxy for EGM	04.07.18
Ovoca Gold : Form of Proxy for AGM	04.07.18
Ovoca Gold : Notice of AGM	04.07.18

Keine Ergebnisse zu dieser Suche